Point: postprandial glucose levels are a clinically important treatment target.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

23 citing papers in PubMed.

1. Use of Metabotyping to Identify Individuals With Different Triglyceride Response Curves After Intake of High-Fat Meals.Molecular nutrition & food research · 2026
   Trial
2. Effects of meal replacement therapy on metabolic outcomes in Thai patients with type 2 diabetes: A randomized controlled trial.Nutrition and health · 2018
   Trial
3. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.Diabetes technology & therapeutics · 2016
   Trial
4. Effects of Acute Ingestion of Native Banana Starch on Glycemic Response Evaluated by Continuous Glucose Monitoring in Obese and Lean Subjects.International journal of environmental research and public health · 2015
   Trial
5. Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells.In vitro cellular & developmental biology. Animal · 2025
   Article
6. Circular RNAs in human diseases.MedComm · 2024
   Review
7. Health relevance of lowering postprandial glycaemia in the paediatric population through diet': results from a multistakeholder workshop.European journal of nutrition · 2023
   Review
8. Neutralization of excessive CCL28 improves wound healing in diabetic mice.Frontiers in pharmacology · 2023
   Article
9. Inhibition of CCL28/CCR10-Mediated eNOS Downregulation Improves Skin Wound Healing in the Obesity-Induced Mouse Model of Type 2 Diabetes.Diabetes · 2022
   Article
10. Personalising activity to target peak hyperglycaemia and improve cardiometabolic health in people with type 2 diabetes: protocol for a randomised controlled trial.BMJ open · 2022
    Article
11. Circular RNAs in diabetes and its complications: Current knowledge and future prospects.Frontiers in genetics · 2022
    Review
12. Upregulation of long non-coding RNA SNHG16 promotes diabetes-related RMEC dysfunction via activating NF-κB and PI3K/AKT pathways.Molecular therapy. Nucleic acids · 2021
    Article
13. Postprandial Glucose Control in Type 1 Diabetes: Importance of the Gastric Emptying Rate.Nutrients · 2019
    Review
14. Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells.Molecular medicine reports · 2019
    Article
15. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy.Diabetologia · 2019
    Article
16. Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin.Diabetology & metabolic syndrome · 2019
    Article
17. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.Cardiovascular diabetology · 2018
    Review
18. Exercise and Health-Related Risks of Physical Deconditioning After Spinal Cord Injury.Topics in spinal cord injury rehabilitation · 2017
    Review
19. A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes.Journal of patient-reported outcomes · 2017
    Article
20. Modulation of coronary heart disease risk by insulin resistance in subjects with normal glucose tolerance or prediabetes.Acta diabetologica · 2014
    Article

Corrections and comments

• Commented on by
  Counterpoint: postprandial glucose levels are not a clinically important treatment target.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as